Maternal & Child Health Research Institute (MCHRI)
Showing 391-400 of 996 Results
-
Ngan F. Huang
Associate Professor of Cardiothoracic Surgery (Cardiothoracic Surgery Research) and, by courtesy, of Chemical Engineering
Current Research and Scholarly InterestsDr. Huang's laboratory aims to understand the chemical and mechanical interactions between extracellular matrix (ECM) proteins and pluripotent stem cells that regulate vascular and myogenic differentiation. The fundamental insights of cell-matrix interactions are applied towards stem cell-based therapies with respect to improving cell survival and regenerative capacity, as well as engineered vascularized tissues for therapeutic transplantation.
-
Louanne Hudgins
Professor of Pediatrics (Genetics) at the Lucile Salter Packard Children's Hospital, Emerita
Current Research and Scholarly InterestsI am interested in prenatal genetic screening and diagnosis.
-
Michelle Huffaker, MD
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Michelle Huffaker is a board-certified, fellowship-trained allergist and immunologist with Stanford Health Care. She is a clinical assistant professor in the Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine at Stanford University School of Medicine.
Dr. Huffaker specializes in diagnosing and treating allergies and health conditions that affect the immune system. She is particularly interested in asthma, food allergies, and allergic rhinitis.
Dr. Huffaker’s research is focused on treatments that achieve long-lasting remission for allergic and immunologic diseases, such as food allergies and allergic rhinitis. Dr. Huffaker is the director of clinical and translational medicine for the allergy portfolio of the Immune Tolerance Network (ITN), a clinical research consortium funded by the National Institute of Allergy and Infectious Diseases (NIAID). The ITN focuses on achieving immune tolerance in conditions where the body attacks healthy cells (immune-mediated diseases). Dr. Huffaker leads the development, conduct, and analysis of ITN clinical trials.
Dr. Huffaker has published her research in peer-reviewed journals, such as Allergy, The Journal of Allergy and Clinical Immunology, and World Allergy Organization Journal. She has presented to her peers at international, national, and regional meetings, including those of the European Academy of Allergy and Clinical Immunology (EAACI), the American Academy of Allergy, Asthma, and Immunology (AAAAI), and the American College of Allergy, Asthma, and Immunology (ACAAI).
Dr. Huffaker is a fellow of AAAAI and a member of AAAAI, EAACI, and the Western Society of Allergy, Asthma, and Immunology. -
Lynne C. Huffman
Professor (Teaching) of Pediatrics (Developmental-Behavioral Pediatrics), Emerita
Current Research and Scholarly InterestsResearch interests and activities include (1) shared decision-making in clinical care; (2) medical education research; (3) the early identification and treatment of behavioral problems, particularly in children with special health care needs; and (4) community-based mental health/educational program evaluation and outcomes measurement.
-
John Huguenard
Professor of Neurology and Neurological Sciences (Neurology Research), of Neurosurgery (Adult Neurosurgery) and, by courtesy, of Molecular and Cellular Physiology
Current Research and Scholarly InterestsWe are interested in the neuronal mechanisms that underlie synchronous oscillatory activity in the thalamus, cortex and the massively interconnected thalamocortical system. Such oscillations are related to cognitive processes, normal sleep activities and certain forms of epilepsy. Our approach is an analysis of the discrete components (cells, synapses, microcircuits) that make up thalamic and cortical circuits, and reconstitution of components into in silico computational networks.
-
Irogue I Igbinosa
Assistant Professor of Obstetrics and Gynecology (Maternal Fetal Medicine & Obstretrics)
BioIrogue Igbinosa, MD, MS, is a Maternal-Fetal Medicine physician at Stanford University. Her research focus includes iron deficiency anemia in pregnancy, severe maternal morbidity and mortality, and health equity. She is a NIH Women's Reproductive Health Scholar (K12) and recently, she was also recognized as the Duan Family Faculty Scholar in Maternal-Fetal Medicine.
She graduated from the University of Houston and earned her medical degree at Baylor College of Medicine. She subsequently completed her residency in Obstetrics and Gynecology Residency at Louisiana State University School of Medicine Baton Rouge. After residency, she was an AAMC-CDC Public Health Policy Fellow able to serve in the CDC Emergency Operations Center and contribute to research for healthcare providers regarding the management of the Zika virus in pregnant persons. She completed her Maternal Fetal Medicine fellowship at Stanford in 2022.
Dr. Igbinosa is passionate about community-engaged approaches to bridge gaps in evidence-based care for birthing communities and collaborates with local and national policy committees to raise awareness for reproductive justice in maternal health. In 2023, 2he was awarded the inaugural Maternal Health Implementation Science Physician Research Scholar with AMETHIST @Penn (Achieving Maternal Empowerment and Transforming Health at University of Pennsylvania) and applies to the principles learned to many aspects of her ongoing research. Her current research endeavors include co-investigator for Stanford's PHRISM: preventing inequities in hemorrhage related severe maternal morbidity, primary investigator for NOURISH - prenatal nutrition education for community health workers and doulas, as well as several hospital quality initiative efforts to improve the screening, management, and treatment of iron deficiency anemia in pregnancy. Her motto is to listen first and serve with compassion. -
Gentaro Ikeda
Instructor, Medicine - Cardiovascular Medicine
BioDr. Ikeda is a physician-scientist who develops innovative diagnostic and therapeutic modalities for patients with cardiovascular disease. Based on his clinical experience as a cardiologist, he has become aware of major clinical shortcomings, specifically in the current pharmaceutical therapies for myocardial infarction (MI) and chronic heart failure (HF). Some evidence-based drug therapies, including β-blockers, ivabradine, and renin-angiotensin-aldosterone antagonists are difficult to apply to critical patients due to adverse side effects. Drugs that have shown efficacy in basic animal experiments have failed to show significant benefits in clinical trials. To address these problems, he moved to academia to conduct translational research. During his graduate training in the Egashira Lab, he focused on drug delivery systems (DDS) that target mitochondria in animal models of MI. He obtained advanced skills in molecular biology, mitochondrial bioenergetics, and animal surgery. He realized the importance of translational research and the great potential of DDS to overcome many clinical problems. He developed nanoparticle-mediated DDS containing cyclosporine for the treatment of patients with MI. He published a first-author paper and received academic awards for his novel science. Since becoming a postdoctoral fellow in the Yang Lab, he has continued to build upon his previous training in translational research. He is currently developing an innovative therapy, namely, extracellular vesicles-mediated mitochondrial transfer for mitochondria-related diseases such as heart failure and mitochondrial disease.
-
Jennifer Ikle
Adjunct Clinical Assistant Professor, Pediatrics - Endocrinology
Current Research and Scholarly InterestsJen is interested in the genetic factors that lead to abnormal beta-cell function and insulin secretion, causing disorders such as hyperinsulinism and neonatal diabetes. Jen’s current research focus is the use of zebrafish models, combined with genetics and genomics, to understand cellular and molecular mechanisms of glucose metabolism and elucidate previously unknown players involved in the regulation of insulin secretion.
-
Daniel Imler
Clinical Associate Professor, Emergency Medicine
Clinical Associate Professor, PediatricsCurrent Research and Scholarly InterestsI am interested in understanding the impact of smart, agile clinical pathways to drive behavior change among providers.
